RISK MITIGATION OF NITROSAMINES FORMATION IN DRUG PRODUCTS:
Role of Excipients

The nitrosamine contamination of drugs and thus also the nitrite content of excipients is currently one of the most important topics for the pharmaceutical industry. Our Head of R&D Ricarda Leister has perfectly summarized this topic in our new white paper which you can download on this page.

If you would like to learn more about how MEGGLE can help you mitigate the risk associated with Nitrosamines, please contact us.